MARK H ERETH, M.D.
Anesthesiologist Assistant at 1 St, Rochester, MN

License number
Minnesota 30431
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511

Professional information

Mark Ereth Photo 1

Physician At Mayo Clinic

Position:
Physician-Scientist at Mayo Clinic
Location:
Rochester, Minnesota Area
Industry:
Medical Practice
Work:
Mayo Clinic since Jul 1989 - Physician-Scientist Cheetah Development Jun 2009 - Nov 2012 - Board Chair
Education:
Mayo Graduate School
The University of North Dakota School of Medicine and Health Sciences
MD, MA, Medicine


Mark H Ereth Photo 2

Dr. Mark H Ereth, Rochester MN - MD (Doctor of Medicine)

Specialties:
Anesthesiology
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Anesthesiology, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mayo Clinic
200 1St St SW, Rochester 55905
Mayo Clinic Saint Marys Hospital
1216 2Nd St South #West, Rochester 55902
Education:
Medical School
University Of North Dakota School Of Medicine
Graduated: 1985
Sioux Vly Hospital
Graduated: 1986
Mayo Grad School Med
Graduated: 1988
Graduated: 1989


Mark Ereth Photo 3

Automated Injection Device For Administration Of Liquid Medicament

US Patent:
6517517, Feb 11, 2003
Filed:
Jun 8, 2000
Appl. No.:
09/589962
Inventors:
Gianrico Farrugia - Rochester MN
Mark H. Ereth - Rochester MN
Jerry Neubauer - Stewartville MN
Jim Rigotti - Rochester MN
Peter Schuller - Rochester MN
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61M 3700
US Classification:
604131, 604138, 604204, 604212
Abstract:
An automated injection device for administration of one or more liquid medicaments that is particularly useful for self-administration of liquid medicaments such as those used to treat anaphylactic shock, heart attack, exposure to toxic agents, or other conditions may include a number of features designed to reduce both the size and complexity of the device. With reduced size, the device may provide greater convenience and portability. Importantly, the reduced size may encourage more users to carry the device, and thereby reduce the risks associated with the conditions mentioned above. With reduced complexity, the device can be constructed at a lower cost. Moreover, the device can be more reliable and simple to operate.


Mark Ereth Photo 4

Mark Ereth, Rochester MN

Work:
Mayo Medical School
200 1St St SW, Rochester, MN 55905


Mark Ereth Photo 5

Automated Injection Device For Administration Of Liquid Medicament

US Patent:
2003017, Sep 11, 2003
Filed:
Dec 5, 2002
Appl. No.:
10/310717
Inventors:
Gianrico Farrugia - Rochester MN, US
Mark Ereth - Rochester MN, US
William Brooks - Rochester MN, US
Jerry Neubauer - Stewartville MN, US
Jim Rigotti - Hayward WI, US
Peter Schuller - Rochester MN, US
Raymond Menard - Hastings MN, US
Curtis Quady - Burnsville MN, US
International Classification:
A61M037/00
US Classification:
604/131000
Abstract:
An automated injection device for administration of one or more liquid medicaments that is particularly useful for self-administration of liquid medicaments such as those used to treat anaphylactic shock, heart attack, exposure to toxic agents, or other conditions may include a number of features designed to reduce both the size and complexity of the device. With reduced size, the device may provide greater convenience and portability. Importantly, the reduced size may encourage more users to carry the device, and thereby reduce the risks associated with the conditions mentioned above. With reduced complexity, the device can be constructed at a lower cost. Moreover, the device can be more reliable and simple to operate. In addition, the automated injection device may further include a wireless communication apparatus that may be activated to call for additional medical assistance when the automated injection device is deployed.


Mark Ereth Photo 6

Process And System For Systematic Oxygenation And Renal Preservation During Retrograde Perfusion Of The Ischemic Kidney

US Patent:
2008024, Oct 2, 2008
Filed:
Aug 22, 2007
Appl. No.:
11/843339
Inventors:
Mitchell R. Humphreys - Scottsdale AZ, US
Mark H. Ereth - Rochester MN, US
Matthew T. Gettman - Rochester MN, US
International Classification:
A61M 37/00
US Classification:
604264
Abstract:
A delivery system to provide end organ oxygenation and even systematic oxygenation in the face of ischemic result. The deliver system including a retrograde oxygenation and perfusion stent. The stent employing at least two and possibly more channels to allow flow of the perfusate from the device to the renal pelvis then to a back out to a collection apparatus. The stent may include various vital sign monitors, such as a renal pressure monitor, temperature monitor, and even an oxygenation monitor. The stent may include an anchoring device to allow the stent to be anchored into the renal pelvis in a temporary way during the retrograde oxygenation process.


Mark Ereth Photo 7

Material Delivery System

US Patent:
6992233, Jan 31, 2006
Filed:
May 31, 2002
Appl. No.:
10/164365
Inventors:
James Franklin Drake - Minneapolis MN, US
Mark Harold Ereth - Rochester MN, US
Lynn R. Skow - North Branch MN, US
Assignee:
MedaFor, Inc. - Minneapolis MN
International Classification:
A61F 13/00
US Classification:
602 48, 424443, 424446, 424447, 424448, 424449, 604304, 604307
Abstract:
A delivery system for the delivery of flowable medicinal, therapeutic or medicine materials has a strip with flowable material contained and restrained therein. A removable seal is provided, so that when the removable seal is removed, the flowable material will flow from a storage area onto a site selected for treatment. The removable seal may be provided with additional features such as absorbent coatings, or additional disinfectants coatings useful in preparing the wound surface to receive the flowable wound treatment material. A preferred composition is a system, article and method for the enhancement of clotting in wounds with extravascular blood flow, especially where the surface of the tissue has been broken.